Cervical surgery may alter blood flow to the uterus
NCT ID NCT07653191
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 50 women aged 30–50 who had a cervical conization (a cone-shaped biopsy) to treat abnormal cervical cells. Researchers measured blood flow in the uterine artery before and one month after surgery using Doppler ultrasound. The goal was to see if the surgery changes resistance in the artery, which could affect future fertility or pregnancy outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors understand how cervical conization affects blood flow to the uterus, potentially guiding safer surgical practices.
- What could go wrong
- This is a small, completed observational study with only 50 participants. It does not test a new treatment, so it cannot directly lead to a cure or therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Jun 2018
- Finished
-
Oct 2018
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 50 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Regularly menstruating female patients aged between 30 and 50 years. 2. Definitive clinical indication for cervical conization based on abnormal cervical cytology, positive HPV screening, or colposcopy-guided biopsy findings. Exclusion Criteria: 1. Concomitant pelvic pathologies that could independently alter uterine artery blood flow or Doppler indices, such as uterine fibroids, ovarian cysts, endometriosis, pelvic inflammatory disease (PID), or hydrosalpinx. 2. Acute postoperative bleeding complications.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical intraepithelial neoplasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Adana City Training and Research Hospital
Adana, 01230, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a portable heat device match cryotherapy for cervical precancer?
- Could a Light-Activated cream replace surgery for cervical precancer?
- Enzyme-HPV link in cervical disease explored
- Anesthesia choice may change surgical outcomes in cervical treatment
- Ice pack on the belly may ease pain after keyhole hysterectomy
- New Self-Sampling and digital colposcopy could speed up cervical cancer detection